Corleen Roche reports an option exercise and tax withholding on shares
By AlphaYouPublished Form 4
Roche Corleen M.
Reporting filer
Corleen Roche reports an option exercise and tax withholding on shares, not an open-market purchase or sale, in Iovance Biotherapeutics, Inc.. Form 4 filed Nov 10, 2026 lists 3 entries.
- Disclosed
- Nov 10, 2026
Reported details
3 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Roche Corleen M. | 2026-11-06 | M | Exercise or conversion | 12500 | 0 | 41,257 | 4 days | Filed terms
|
| Common Stock | Roche Corleen M. | 2026-11-06 | F | Tax/exercise withholding | 5311 | 8.04 | 35,946 | 4 days | Filed terms
|
| Restricted Stock Units (derivative) | Roche Corleen M. | 2026-11-06 | M | Exercise or conversion | 12500 | 0.00 | 87,505 | 4 days | Filed terms
|
Common Stock
- Owner
- Roche Corleen M.
- Date
- 2026-11-06
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 12500
- Price
- 0
- Following holdings
- 41,257
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- id: F1
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 12500
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 41257
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Roche Corleen M.
- Date
- 2026-11-06
- Code
- F
- Action
- Tax/exercise withholding
- Quantity
- 5311
- Price
- 8.04
- Following holdings
- 35,946
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-06
- id: F2
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: F
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 5311
- transaction Price Per Share: 8.04
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 35946
- id: F3
- direct Or Indirect Ownership: D
Restricted Stock Units (derivative)
- Owner
- Roche Corleen M.
- Date
- 2026-11-06
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 12500
- Price
- 0.00
- Following holdings
- 87,505
- Reporting delay
- 4 days
- Filed terms and references
Filed terms
- security Title: Restricted Stock Units
- id: F4
- transaction Date: 2026-11-06
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 12500
- transaction Price Per Share: 0.00
- transaction Acquired Disposed Code: D
- id: F5
- id: F5
- underlying Security Title: Common Stock
- underlying Security Shares: 12500
- shares Owned Following Transaction: 87505
- id: F6
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Roche Corleen M.: Chief Financial Officer.
- F1: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
- F2: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
- F3: Represents the common stock remaining after deducting the common stock withheld for taxes.
- F4: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- F5: The remaining RSUs will vest in equal quarterly installments.
- F6: Such aggregate number reflects the remainder of such RSUs granted on August 6, 2025, but does not include any other RSUs held by such Reporting Person.
Original sources
Prepared automatically from public filing data. Report a correction.